In a non‑pregnant adult without severe liver or kidney disease or doxycycline allergy, what is the appropriate doxycycline post‑exposure prophylaxis regimen for bacterial sexually transmitted infections?

Doxycycline Post-Exposure Prophylaxis (Doxy PEP) for Bacterial STI Prevention

For eligible adults without contraindications, prescribe 200 mg of doxycycline (any formulation) to be taken as a single dose within 72 hours after condomless oral, vaginal, or anal sex, with a maximum of 200 mg per 24-hour period. 1

Who Should Receive Doxy PEP

Recommended Populations

• Men who have sex with men (MSM) who have had at least one bacterial STI (gonorrhea, chlamydia, or syphilis) diagnosed in the past 12 months 1
• Transgender women with the same STI history 1
• Both HIV-positive and HIV-negative individuals in these groups benefit equally 2, 3

May Consider (Shared Decision-Making)

• MSM and transgender women without a recent bacterial STI diagnosis but who anticipate high-risk sexual activities 1

Not Recommended

• Cisgender women: Evidence shows no significant benefit (RR 0.88,95% CI 0.60-1.29, P=0.51), likely due to poor adherence and high baseline gonococcal resistance 4
• Cisgender heterosexual men: Insufficient evidence 1
• Transgender men and other queer/nonbinary persons: Insufficient evidence 1

Dosing Regimen

Core prescription details:

• Dose: 200 mg doxycycline (single dose)
• Timing: As soon as possible after sex, but no later than 72 hours post-exposure 1
• Frequency limit: Maximum 200 mg per 24-hour period (do not take daily doses closer than 24 hours apart) 1
• Quantity: Prescribe enough doses based on anticipated sexual frequency until next follow-up visit 1

Expected Efficacy

Doxy PEP reduces bacterial STI incidence by approximately 60-66% overall 2, 3:

• Chlamydia: 76-88% reduction (most effective) 3, 5
• Syphilis: 78-87% reduction 3, 5
• Gonorrhea: 33-57% reduction (variable, depends on local tetracycline resistance) 3, 5

The absolute risk reduction is substantial: STI incidence drops from 30-32% per quarter to 11-12% per quarter 2, 3.

Administration Instructions (Critical for Patient Counseling)

To Prevent Esophagitis

• Take with a full glass of liquid and a full stomach (food or milk) 1
• Remain upright for 1 hour after taking (do not lie down) 1

Drug Interactions

• Separate by at least 2 hours from: dairy products, antacids, calcium, iron, magnesium, or sodium bicarbonate supplements 1
• No interaction with gender-affirming hormonal therapy 1
• Review all medications (including over-the-counter) for potential interactions 1

Common Side Effects

• Photosensitivity (sun sensitivity)
• Gastrointestinal symptoms (nausea, vomiting, diarrhea)
• Esophagitis/esophageal discomfort 1

Required Clinical Services

Initial Visit

• STI screening: NAAT for gonorrhea/chlamydia at all exposure sites (oral, rectal, urogenital) plus syphilis serology 1
• HIV screening: Per PrEP guidelines if on PrEP; otherwise consider every 3-6 months 1
• Comprehensive counseling on benefits, harms, antimicrobial resistance concerns, and proper use 1
• Prescribe sufficient doses until next visit based on sexual activity assessment 1

Follow-Up Every 3-6 Months

• Repeat STI screening at all exposure sites 1
• Assess for side effects 1
• Reassess continued need for doxy PEP 1
• Provide risk reduction counseling and condoms 1
• Represcribe based on ongoing need 1

Critical Caveats

Antimicrobial Resistance Concerns

While doxy PEP is highly effective, surveillance data show rapid increases in gonococcal tetracycline resistance in areas with high uptake 6. In the DoxyPEP trial, tetracycline-resistant gonorrhea occurred in 27% of doxy PEP users vs. 24% of controls—not significantly different but concerning at population level 2. All N. gonorrhoeae isolates in the cisgender women trial were doxycycline-resistant 4.

Important: No cephalosporin resistance has been linked to doxy PEP yet, but genomic surveillance is essential 6.

Microbiome Effects

Doxy PEP alters the functional resistome, amplifying tetracycline resistance genes in gut, skin, and oropharyngeal flora 6. Long-term effects remain unknown 1.

Not a Replacement for Other Prevention

Doxy PEP should be part of a comprehensive sexual health approach including condoms, partner reduction counseling, HIV PrEP linkage, and vaccination 1. It does not prevent HIV, viral STIs, or other infections.

Contraindications (From Standard Doxycycline Use)

• Pregnancy (not addressed in guidelines but standard contraindication)
• Severe liver disease
• Severe renal impairment (though standard doses don't accumulate excessively) 7
• Doxycycline allergy

The 2024 CDC guidelines 1 represent the most authoritative and recent evidence, supported by robust RCT data from the DoxyPEP trial 2, 3 showing consistent benefit in MSM and transgender women populations where bacterial STI burden is highest.